Literature DB >> 15452229

Characterization of Nef-CXCR4 interactions important for apoptosis induction.

Ming-Bo Huang1, Ling Ling Jin, Cleve O James, Mahfuz Khan, Michael D Powell, Vincent C Bond.   

Abstract

The HIV-1 Nef protein was analyzed for apoptotic structural motifs that interact with the CXCR4 receptor and induce apoptosis in CD4(+) lymphocytes. Two apoptotic motifs were identified. One centered on Nef amino acids (aa) 50 to 60, with the overlapping 20-mer peptides retaining about 82% of the activity of the full Nef protein. The second centered on aa 170 to 180, with the overlapping 20-mer peptides retaining about 30% of the activity of the full protein. Significant apoptotic abilities were observed for 11-mer motif peptides spanning aa 50 to 60 and aa 170 to 180, with a scrambled version of the 11-mer motif peptide corresponding to aa 50 to 60 showing no apoptotic ability. Hallmarks of apoptosis, such as the formation of DNA ladders and caspase activation, that were observed with the full-length protein were equally evident upon exposure of cells to these motif peptides. A CXCR4 antibody and the endogenous ligand SDF-1alpha were effective in blocking Nef peptide-induced apoptosis as well as the physical binding of a fluorescently tagged Nef protein, while CCR5 antibodies were ineffective. The CXCR4-negative cell line MDA-MB-468 was resistant to the apoptotic peptides and became sensitive to the apoptotic peptides upon transfection with a CXCR4-expressing vector. A fluorescently tagged motif peptide and Nef protein displayed physical binding to CXCR4-transfected MDA-MB-468 cells, but not to CCR5-transfected cells. The removal of the apoptotic motif sequences from the full-length protein completely eliminated the ability of Nef to induce apoptosis. However, these modified Nef proteins still retained the ability to enhance viral infectivity. Thus, specific sequences in the Nef protein appear to be necessary for Nef protein-induced apoptosis as well as for physical interaction with CXCR4 receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452229      PMCID: PMC521796          DOI: 10.1128/JVI.78.20.11084-11096.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  112 in total

Review 1.  From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef.

Authors:  M Harris
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

2.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

Authors:  L Wu; N P Gerard; R Wyatt; H Choe; C Parolin; N Ruffing; A Borsetti; A A Cardoso; E Desjardin; W Newman; C Gerard; J Sodroski
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

3.  Dual role of HIV Tat in regulation of apoptosis in T cells.

Authors:  T W McCloskey; M Ott; E Tribble; S A Khan; S Teichberg; M O Paul; S Pahwa; E Verdin; N Chirmule
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

4.  Down or out in blood and lymph?

Authors:  S Wain-Hobson
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

5.  The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; A Cara; R C Gallo; P Lusso
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

6.  Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.

Authors:  R F Speck; K Wehrly; E J Platt; R E Atchison; I F Charo; D Kabat; B Chesebro; M A Goldsmith
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells.

Authors:  Y Fujii; K Otake; M Tashiro; A Adachi
Journal:  FEBS Lett       Date:  1996-09-09       Impact factor: 4.124

8.  Human immunodeficiency virus type 1 Nef protein on the cell surface is cytocidal for human CD4+ T cells.

Authors:  Y Fujii; K Otake; M Tashiro; A Adachi
Journal:  FEBS Lett       Date:  1996-09-09       Impact factor: 4.124

9.  HIV type 1 Nef perturbs eye lens development in transgenic mice.

Authors:  P Dickie
Journal:  AIDS Res Hum Retroviruses       Date:  1996-02-10       Impact factor: 2.205

10.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Authors:  C C Bleul; R C Fuhlbrigge; J M Casasnovas; A Aiuti; T A Springer
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  24 in total

1.  Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling.

Authors:  Patrick E Campbell; Olexandr Isayev; Syed A Ali; William W Roth; Ming-Bo Huang; Michael D Powell; Jerzy Leszczynski; Vincent C Bond
Journal:  J Mol Model       Date:  2012-05-30       Impact factor: 1.810

2.  HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

Authors:  John C Marecki; Carlyne D Cool; Jane E Parr; Virginia E Beckey; Paul A Luciw; Alice F Tarantal; Angela Carville; Richard P Shannon; Adela Cota-Gomez; Rubin M Tuder; Norbert F Voelkel; Sonia C Flores
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

3.  HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions.

Authors:  Tamika D Campbell; Mahfuz Khan; Ming-Bo Huang; Vincent Craig Bond; Michael D Powell
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

4.  Peptide-based identification of functional motifs and their binding partners.

Authors:  Martin N Shelton; Ming Bo Huang; Syed Ali; Kateena Johnson; William Roth; Michael Powell; Vincent Bond
Journal:  J Vis Exp       Date:  2013-06-30       Impact factor: 1.355

5.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

6.  Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase.

Authors:  Bryan D Cox; Anthony R Prosser; Yongnian Sun; Zhufang Li; Sangil Lee; Ming B Huang; Vincent C Bond; James P Snyder; Mark Krystal; Lawrence J Wilson; Dennis C Liotta
Journal:  ACS Med Chem Lett       Date:  2015-05-06       Impact factor: 4.345

7.  HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis.

Authors:  Willie Harrington; Vincent Bond; Ming Bo Huang; Michael Powell; James Lillard; Upender Manne; Harvey Bumpers
Journal:  Mol Cell Pharmacol       Date:  2009-08-05

8.  Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals.

Authors:  Kateena Addae Konadu; Ming Bo Huang; William Roth; Wendy Armstrong; Michael Powell; Francois Villinger; Vincent Bond
Journal:  J Vis Exp       Date:  2016-01-05       Impact factor: 1.355

9.  In vitro treatment of human monocytes/macrophages with myristoylated recombinant Nef of human immunodeficiency virus type 1 leads to the activation of mitogen-activated protein kinases, IkappaB kinases, and interferon regulatory factor 3 and to the release of beta interferon.

Authors:  Giorgio Mangino; Zulema A Percario; Gianna Fiorucci; Gabriele Vaccari; Santiago Manrique; Giovanna Romeo; Maurizio Federico; Matthias Geyer; Elisabetta Affabris
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

10.  Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization.

Authors:  Nilanjana Sengupta; Aqeela Afzal; Sergio Caballero; Kyung-Hee Chang; Lynn C Shaw; Ji-Jing Pang; Vincent C Bond; Imran Bhutto; Takayuki Baba; Gerard A Lutty; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-10       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.